BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghaffari Rahbar M, Nafar M, Khoshdel A, Dalili N, Abrishami A, Firouzan A, Poorrezagholi F, Samadian F, Ziaie S, Fatemizadeh S, Samavat S. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response? Transpl Infect Dis 2020;22:e13406. [PMID: 32654357 DOI: 10.1111/tid.13406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Navari Y, Bagheri AB, Akhavan Rezayat A, SeyedAlinaghi S, Najafi S, Barzegary A, Asadollahi-Amin A. Mortality risk factors in kidney-transplanted patients with COVID-19: A systematic review and regression analysis. Health Sci Rep 2021;4:e427. [PMID: 34761124 DOI: 10.1002/hsr2.427] [Reference Citation Analysis]
2 Hasan I, Rashid T, Suliman S, Amer H, Chirila RM, Mai ML, Jarmi T, Khouzam S, Franco PM, Heilig CW, Wadei HM. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample. Rom J Intern Med 2021;59:10-42. [PMID: 33155999 DOI: 10.2478/rjim-2020-0034] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Varikasuvu SR, Varshney S, Dutt N, Munikumar M, Asfahan S, Kulkarni PP, Gupta P. D-dimer, disease severity, and deaths (3D-study) in patients with COVID-19: a systematic review and meta-analysis of 100 studies. Sci Rep 2021;11:21888. [PMID: 34750495 DOI: 10.1038/s41598-021-01462-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Devaux CA, Melenotte C, Piercecchi-Marti MD, Delteil C, Raoult D. Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? Front Med (Lausanne) 2021;8:663708. [PMID: 34552938 DOI: 10.3389/fmed.2021.663708] [Reference Citation Analysis]
5 Ghaffari Rahbar M, Nafar M, Khoshdel A, Dalili N, Abrishami A, Firouzan A, Poorrezagholi F, Samadian F, Ziaie S, Fatemizadeh S, Samavat S. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response? Transpl Infect Dis 2020;22:e13406. [PMID: 32654357 DOI: 10.1111/tid.13406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Quante M, Brake L, Tolios A, Della Penna A, Steidle C, Gruendl M, Grishina A, Haeberle H, Guthoff M, Tullius SG, Königsrainer A, Nadalin S, Löffler MW. SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020. Transplant Proc 2021;53:2421-34. [PMID: 34551880 DOI: 10.1016/j.transproceed.2021.08.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Değirmenci MFK, Yalçındağ FN, Tugal-Tutkun İ. COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology. Turk J Ophthalmol 2021;51:231-42. [PMID: 34461710 DOI: 10.4274/tjo.galenos.2021.68252] [Reference Citation Analysis]
8 Qiu L, Zhang J, Huang Y, Chen G, Chen Z, Ming C, Lu X, Gong N. Long-Term Clinical and Immunological Impact of Severe COVID-19 on a Living Kidney Transplant Recipient - A Case Report. Front Immunol 2021;12:741765. [PMID: 34567007 DOI: 10.3389/fimmu.2021.741765] [Reference Citation Analysis]